Biosimilars Market - Forecast(2022 - 2027)

1
Biosimilars MarketMarket size, Industry
outlook, Market Forecast, Demand Analysis, Market
Share, Market Report 2022-2027
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• Biosimilars are alternatives to existing
  biological medicines. Since biological medicines
  are expensive for certain sections of the
  population, the biosimilar vertical in the
  pharmaceuticals industry is gaining popularity.
• According to the Biosimilars Council, biosimilars
  are priced 10 to 35 lesser than branded
  biological medicines, and a sum of 250 billion
  could be saved through application of biosimilars
  in the next decade. Biosimilars will increase
  patient access to important life-saving
  medication by reducing overall costs in the
  pharmaceutical industry.
• The global biosimilars market, which was valued
  at 5.5 billion in 2018, is estimated to grow at
  a CAGR of 38.21 during the forecast period of
  2019 to 2025.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• It is very common to see multiple key players
  entering the market with the same drugs at the
  same time which further increases the competition
  in the global biosimilars market.
• This ongoing competition among the key players to
  establish an economical and efficient biosimilar
  is leading the companies to invest in their
  research and development and come up with
  extra-ordinary and affordable drug.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure

• By Distribution Channel- Segment Analysis
• Biosimilar medication can be used for most
  diseases including chronic disease, cancerous
  diseases, cardiovascular, and others. However,
  the oncology disease segment is the key
  application for the biosimilars market.
• The oncology disease application in the
  biosimilars market is growing at a CAGR of 41.58
  through the forecast period.
• Other diseases augmenting the demands in the
  global biosimilars market are autoimmune diseases
  such as inflammatory bowel disease, psoriasis,
  and arthritis.

Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Biosimilars Market Industry Outlook 
• Stada Arzneimittel AG
• C.H. Boehringer Ingelheim AG Ko
• Amgen Inc, Merck Co. Inc
• Allergan Plc
• Eli Lilly and Company
• Dr. Reddy's Laboratories
• Pfizer Inc
• Samsung Bioepis Co., Ltd
• Celltrion Healthcare Co. Ltd
• Novartis International AG
• Biogen Inc

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Biosimilars Market - Forecast(2022 -
2027) Learn More About the Report _at_
https//www.industryarc.com/Report/10593/biosimil
ars-market.html
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_ https//www.industryarc.com
  /purchasereport.php?id10593

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com